Diagnostics
What if infants with genetic illnesses could be diagnosed in a matter of days? New research surrounding rapid whole genome sequencing suggests that soon, they could be.
It’s a new month and a new chapter for several life sciences executives. Here’s a look at some notable Movers & Shakers beginning April with new companies.
The data showed mixed end results, but the diagnostics involved in treating Alzheimer’s were the star of the conference.
Although at-home testing for COVID-19 has been dismal, the revolution in at-home testing has inspired personal tests for several other illnesses.
A recent study, published in Genetics in Medicine, concluded that genetic variants contributed to SUPD in 11% of the 352 cases.
“We were founded on the premise of felines first, and have been called ‘23andMeow,’ Anna Skaya, founder and CEO, told BioSpace.
Up to 40% of AD patients were found to have Lewy Bodies in their brain after succumbing to the disease.
Microbiologics, Inc. commemorated its 50th anniversary in 2021 by playing a key role in helping the world manage the COVID-19 pandemic.
You are what you eat, and your defense system notices that.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
PRESS RELEASES